Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
2,157,546
-
Share change
-
+461,738
-
Total reported value
-
$48,835,109
-
Price per share
-
$22.63
-
Number of holders
-
59
-
Value change
-
+$10,354,691
-
Number of buys
-
24
-
Number of sells
-
23
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q4 2024
As of 31 Dec 2024 ISHARES TR - GENOMICS IMMUN (IDNA) had 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,157,546 shares of stock of the company.
Largest 10 holders included UBS Group AG, MORGAN STANLEY, Wharton Business Group, LLC, BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, FLOW TRADERS U.S. LLC, Clearwater Capital Advisors, LLC, Royal Bank of Canada, AMERIPRISE FINANCIAL INC, and Lido Advisors, LLC.
This table shows 59 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.